Efficacy of electrochemotherapy for eruptive legs keratoacanthomas.
Generalized eruptive keratoacanthoma, is considered a serious condition because the eruptions are diffuse, persistent, and recurrent. Constant pruritus, visceral neoplasms, and unsatisfactory response to treatment are ominous prognostic factors. Even if skin cancers are usually well controlled with surgical and/or radiotherapic approaches, there are some cases in which these two techniques are not effective. With respect to surgery, radiotherapy and other standard treatments, ECT acts rapidly on multiple lesions with limited side effects and no functional impairment; moreover, repeated sessions can be performed to achieve or maintain the clinical response. We report a case of generalized eruptive keratoacanthomas in which electrochemotherapy was effective in inducing local regression of skin lesions. A 72-year-old woman with eruptive and painful keratoacanthomas for 3 months on both the lower limbs in which the conventional treatments could not be cosmetically acceptable. One session of electrochemotherapy with bleomycin sulfate was then performed on all isolated skin lesions. The treatment was well tolerated and led to a rapid clinical regression of the treated lesions. Use of ECT should be considered as an excellent alternative to current therapies in treatment of painful eruptive keratoacanthomas with a significant improvement of quality of life.
Department of Dermatologic Surgery, AOU Citta' della Salute e della Scienza di Torino, Turin, Italy. simone.ribero@unito.it.|Department of Medical Sciences, University of Turin, Turin, Italy. simone.ribero@unito.it.
S
S
Ribero
Department of Dermatologic Surgery, AOU Citta' della Salute e della Scienza di Torino, Turin, Italy.
E
E
Balagna
Department of Dermatologic Surgery, AOU Citta' della Salute e della Scienza di Torino, Turin, Italy.
E
E
Sportoletti Baduel
Department of Dermatologic Surgery, AOU Citta' della Salute e della Scienza di Torino, Turin, Italy.
F
F
Picciotto
Department of Medical Sciences, University of Turin, Turin, Italy.
M
M
Sanlorenzo
Department of Medical Sciences, University of Turin, Turin, Italy.
M T
MT
Fierro
Department of Medical Sciences, University of Turin, Turin, Italy.
P
P
Quaglino
Department of Dermatologic Surgery, AOU Citta' della Salute e della Scienza di Torino, Turin, Italy.
G
G
Macripo
D000368:Aged; D001761:Bleomycin / Q000008:administration & dosage*; D003879:Dermatologic Agents / Q000008:administration & dosage*; D053672:Electrochemotherapy; D005260:Female; D006801:Humans; D007636:Keratoacanthoma / Q000175:diagnosis / Q000188:drug therapy*; D007866:Leg; D012074:Remission Induction; D012867:Skin / Q000187:drug effects* / Q000473:pathology; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D003879:Dermatologic Agents; D001761:Bleomycin
electrochemotherapy; keratoacanthomas; paraneoplastic syndrome; surgery